Dithranol, 99%, MP Biomedicals™

Description

Dithranol ≥99%, Yellow Powder

• Dithranol, a potential anti-psoriasis medication, may be used to study its safety, efficacy, metabolism and pharmacological profile.
• It may be used to study is physicochemical properties, as a reference compound and to develop effective drug delivery vehicles.
• It may be used as a matrix for matrix assisted laser desorption/ionization imaging on a Fourier transform ion cyclotron resonance mass spectrometer.
• Anthralin is a leukotriene biosynthesis inhibitor.
• Inhibits LTB4 ω-oxidation and disrupts mitochondria function.
• Anthralin is used in the treatment of psoriasis, as a fungicide, in the treatment of ringworm infections and in chronic dermatoses.

Specifications

Chemical Identifiers

• CAS: 1143-38-0
• Molecular Formula: C14H10O3
• Molecular Weight (g/mol): 226.23
• MDL Number: MFCD00053409
• InChI Key: NUZWLKWWNNJHPT-UHFFFAOYSA-N
• PubChem CID: 2202
• ChEBI: CHEBI:37510
• IUPAC Name: 1,8-dihydroxy-9,10-dihydroanthracen-9-one
• SMILES: OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2

• Color: Orange-Yellow or Yellow
• Assay Percent Range: ≥99%
• Quantity: 0.25 g
• Synonym: anthralin, dithranol, 1,8-dihydroxyanthrone, 1,8-dihydroxy-9-anthrone, chrysodermol, cigthranol, batridol, cignolin, psoriacid-stift, 9 10h-anthracenone, 1,8-dihydroxy
• Formula Weight: 226.23
• Physical Form: Crystalline Powder
• Chemical Name or Material: Dithranol

Safety and Handling

EINECSNumber	214-538-0
Recommended Storage	Store at Room Temperature (15°to 30°C)

WARNING: Cancer - www.P65Warnings.ca.gov